{
    "2019-05-23": [
        [
            {
                "time": "",
                "original_text": "医药生物行业2019q1业绩前瞻-2019q1医药板块整体增长稳健,个股业绩持续分化",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2019q1",
                        "业绩",
                        "增长",
                        "个股分化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "爱尔眼科董事长陈邦：市场足够大，现在仍看不到天花板",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "陈邦",
                        "市场",
                        "天花板"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}